UBS AM’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16B | Buy |
|
|||||
|
2025
Q1 | $1.16B | Buy |
|
|||||
|
2024
Q4 | $868M | Buy |
|
|||||
|
2024
Q3 | $1.12B | Buy |
|
|||||
|
2024
Q2 | $1.15B | Buy |
|
|||||
|
2024
Q1 | $865M | Sell |
|
|||||
|
2023
Q4 | $805M | Buy |
|
|||||
|
2023
Q3 | $734M | Buy |
|
|||||
|
2023
Q2 | $735M | Hold |
|
|||||
|
2023
Q1 | $735M | Sell |
|
|||||
|
2022
Q4 | $835M | Buy |
|
|||||
|
2022
Q3 | $721M | Sell |
|
|||||
|
2022
Q2 | $806M | Buy |
|
|||||
|
2022
Q1 | $540M | Sell |
|
|||||
|
2021
Q4 | $523M | Sell |
|
|||||
|
2021
Q3 | $646M | Buy |
|
|||||
|
2021
Q2 | $437M | Sell |
|
|||||
|
2021
Q1 | $449M | Sell |
|
|||||
|
2020
Q4 | $542M | Sell |
|
|||||
|
2020
Q3 | $469M | Buy |
|
|||||
|
2020
Q2 | $442M | Buy |
|
|||||
|
2020
Q1 | $373M | Sell |
|
|||||
|
2019
Q4 | $550M | Sell |
|
|||||
|
2019
Q3 | $500M | Buy |
|
|||||
|
2019
Q2 | $529M | Sell |
|
|||||
|
2019
Q1 | $571M | Buy |
|
|||||
|
2018
Q4 | $511M | Sell |
|
|||||
|
2018
Q3 | $546M | Sell |
|
|||||
|
2018
Q2 | $514M | Buy |
|
|||||
|
2018
Q1 | $408M | Sell |
|
|||||
|
2017
Q4 | $435M | Buy |
|
|||||
|
2017
Q3 | $329M | Buy |
|
|||||
|
2017
Q2 | $298M | Buy |
|
|||||
|
2017
Q1 | $145M | Buy |
|
|||||
|
2016
Q4 | $116M | Sell |
|
|||||
|
2016
Q3 | $113M | Buy |
|
|||||
|
2016
Q2 | $113M | Buy |
|
|||||
|
2016
Q1 | $119M | Sell |
|
|||||
|
2015
Q4 | $133M | Sell |
|
|||||
|
2015
Q3 | $231M | Sell |
|
|||||
|
2015
Q2 | $289M | Buy |
|
|||||
|
2015
Q1 | $268M | Buy |
|
|||||
|
2014
Q4 | $186M | Buy |
|
|||||
|
2014
Q3 | $168M | Buy |
|
|||||
|
2014
Q2 | $145M | Sell |
|
|||||
|
2014
Q1 | $138M | Buy |
|
|||||
|
2013
Q4 | $115M | Buy |
|
|||||
|
2013
Q3 | $104M | Buy |
|
|||||
|
2013
Q2 | $102M | Buy |
|